Jupiter Neurosciences, Inc.
JUNS
$1.33
-$0.03-2.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 62.72% | 132.19% | |||
| Gross Profit | -62.72% | -132.19% | |||
| SG&A Expenses | 40.52% | -14.80% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 47.26% | 5.46% | |||
| Operating Income | -47.26% | -5.46% | |||
| Income Before Tax | -47.36% | -0.09% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -47.36% | -0.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -47.36% | -0.09% | |||
| EBIT | -47.26% | -5.46% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -46.97% | 4.35% | |||
| Normalized Basic EPS | -46.71% | -2.12% | |||
| EPS Diluted | -51.52% | 4.35% | |||
| Normalized Diluted EPS | -46.71% | -2.12% | |||
| Average Basic Shares Outstanding | 0.23% | 4.62% | |||
| Average Diluted Shares Outstanding | 0.23% | 4.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||